ISOSULFAN BLUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Isosulfan Blue, and what generic alternatives are available?
Isosulfan Blue is a drug marketed by Am Regent, Beloteca, Eugia Pharma, Fresenius Kabi Usa, Meitheal, MSN, Mylan Institutional, and Somerset Theraps Llc. and is included in eight NDAs.
The generic ingredient in ISOSULFAN BLUE is isosulfan blue. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isosulfan Blue
A generic version of ISOSULFAN BLUE was approved as isosulfan blue by MYLAN INSTITUTIONAL on July 20th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOSULFAN BLUE?
- What are the global sales for ISOSULFAN BLUE?
- What is Average Wholesale Price for ISOSULFAN BLUE?
Summary for ISOSULFAN BLUE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Clinical Trials: | 15 |
| Patent Applications: | 282 |
| Drug Prices: | Drug price information for ISOSULFAN BLUE |
| DailyMed Link: | ISOSULFAN BLUE at DailyMed |
Recent Clinical Trials for ISOSULFAN BLUE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| OnLume Inc. | N/A |
| National Institutes of Health (NIH) | N/A |
| University of Wisconsin, Madison | N/A |
US Patents and Regulatory Information for ISOSULFAN BLUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 210294-001 | May 17, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Institutional | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 090874-001 | Jul 20, 2010 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 211869-001 | Sep 8, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Somerset Theraps Llc | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 210558-001 | Jul 12, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Beloteca | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 210714-001 | Jan 16, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 206831-001 | Feb 2, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Msn | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 216090-001 | Sep 16, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
